Vaccine Against Epstein-Barr Virus in Early Trials at NIAID
Mononucleosis might be called the "kissing disease," but there is nothing benign about it. Some percentage of usually young patients end up with longer term complications, and the Epstein-Barr virus infection has been linked to several types of cancers. That's why a preventive vaccine from the National Institute of Allergy and Infectious Diseases (NIAID) is under development. Read more.

Male Versus Female Response to RZV After HSCT
Hematopoietic stem cell transplantation (HSCT) patients are at an especially high risk of reactivation of the varicella-zoster virus. Find out what effect the adjuvant recombinant zoster vaccine (RZV) had on preventing infection and reactivation, and how researchers explained a better response in men versus women after HSCT.

Concern About COVID-19 Shots Heightened Overall Vaccine Hesitancy
Intense controversy, often fueled by misinformation, about COVID-19 vaccines might have had an effect beyond just driving down the number of recipients. A new study in the Journal of Behavioral Medicine suggests that negative coverage of those issues might have led to greater hesitancy to receive any vaccines. The authors said that this might especially be the case with younger people. Read more.